Description
AOD 9604 5mg Core Metrics
Technical specification parameters optimized for integrating high-purity AOD 9604 into focused metabolic screening rows.
| Research Parameter | Assay Benchmark Profile | Internal Catalog Link |
|---|---|---|
| Sequence Blueprint | Modified hGH C-Terminus (176-191 Peptide Fragment Base) | High-Purity Series → |
| Purity Baseline | ≤ 98.0% via High-Performance HPLC | Metabolic Series → |
What is AOD 9604 Peptide?
What is AOD 9604 Peptide?
AOD 9604 (Advanced Obesity Drug 9604) is a highly purified synthetic peptide analogue derived explicitly from the C-terminal region of human growth hormone (hGH). This specific fragment isolates the fat-reducing properties of the full-length hormone without interacting with insulinotropic growth paths. By mirroring the 176-191 amino acid sequence layout with a strategic structural refinement, AOD 9604 retains an exceptional focus on lipid mobilization. In laboratory cell cultures, it serves as a baseline model for evaluating adipose tissue signaling, skipping the secondary systemic growth effects typically linked to native growth factor lines.
AOD 9604 Peptide Quick Specifications
| Technical Property | Laboratory Standard Specifications |
|---|---|
| Chemical Structure | Modified hGH C-Terminal Fragment (Tyrosine Stabilized) |
| Purity Baseline | ≥ 98.0% Pure Certified via HPLC Testing |
| Product Appearance | Sterile filtered, white uniform lyophilized powder cake |
| Primary Research Focus | Beta-3 Adrenergic signaling, lipolysis velocity, and fat cell culture mapping |
How Does AOD 9604 Work in Laboratory Assays?
AOD 9604 operates by directly targeting cell structures responsible for governing lipolytic pathways across adipocyte membranes. This synthetic fragment stimulates natural lipid breakdown mechanisms without binding to hGH cellular receptors that direct IGF-1 transcription updates. As a result, researchers can isolate and observe pure lipid breakdown metrics natively, completely free from erratic data noise tied to secondary glucose intolerance or cellular proliferation anomalies inside the testing pool.
AOD 9604 Research Applications
AOD 9604 Research Applications
In analytical endocrinology and metabolic profiling literature, standalone AOD 9604 is heavily tracked for its distinct lipid-clearing properties. Investigators utilize this synthetic fragment to analyze fat cell development and measure the deceleration of tissue fat accumulation under controlled settings. The 5mg presentation format is specifically favored for running targeted micro-scale trials, allowing researchers to build precise concentration curves without risking the data distortion linked to larger volume fluid packages.
AOD 9604 Core Pathways & Action Matrix
The table below consolidates the primary cellular pathways, biological markers, and research objectives tracked during AOD 9604 5mg laboratory testing lines:
| Target Pathway | Observed Cellular Action | Primary Research Goal |
|---|---|---|
| Lipolysis Activation | Stimulates cell mechanisms to break down stored triglycerides into free fatty acids smoothly. | Quantifying lipid clearing speed across mature fat cell cultures. |
| Fat Reduction Kinetics | Inhibits downstream fat-building signals near pre-adipocyte cell boundaries to prevent tissue accumulation. | Studying the prevention of new cellular fat tissue generation. |
| Growth Receptor Bypass | Completely bypasses standard growth paths, keeping insulin-like growth factor (IGF-1) baseline indicators stable. | Isolating metabolic changes from unguided cellular growth noise. |
Step-by-Step Mechanism of Action
When AOD 9604 is introduced to the target sample research media, it manages structural metabolic changes through a highly standardized sequence path:
- Receptor Protection: The peptide slides past traditional growth hormone receptors, keeping nuclear insulin-resistance pathways undisturbed.
- Active Fat Mobilization: Interacts with localized adrenergic pathways, signaling the cell matrix to release intracellular fatty acid blocks.
- Triglyceride Breakdown: Activates cellular enzymes to begin immediate breakdown paths within mature cells, transforming solid fats into transportable fluid parameters.
- Metabolic Equilibrium: The cell lines demonstrate a clean drop in total lipid accumulation while cellular preservation profiles remain fully stable.
How Does AOD 9604 Compare to Other Research Peptides?
How Does AOD 9604 Compare to Other Research Peptides?
To assist in protocol coordination, it is essential to differentiate the selective lipolytic focus of AOD 9604 5mg from alternative metabolic and structural tracks available in our collection. While alternative compounds monitor pancreatic incretin receptors or cellular locomotion profiles, AOD 9604 targets lipid metabolism parameters exclusively. Understanding these baseline differences allows for more precise laboratory assay designs.
Peptide Quick Comparison Matrix
The comparative table below outlines the core differences in research focus, mechanism of action, and primary target nodes across our high-purity laboratory peptide catalog:
| Research Peptide | Mechanism of Action | Primary Laboratory Focus | Target Nodes | Peptide Structure |
|---|---|---|---|---|
| AOD 9604 5mg (This Product) | Selective Adrenergic Activity | Accelerating lipid breakdown, triglyceride clearing, and non-glycemic metabolic models. | Adipocyte Matrix | 16-AA C-Term Fragment |
| HGH Fragment | Lipolytic Pathway Trigger | Adipose tissue reduction mapping, fat burning markers, and growth-independent structural research. | Beta-3 Receptors | 176-191 Segment |
| Cagrilintide 10mg | Non-Selective AMYR Agonism | CTR-RAMP complex co-activation, satiety signaling paths, and postprandial glucagon control. | AMYR / Hindbrain | Acylated Polypeptide |
| Explore advanced formulations & single lots: | Peptide Blends → All Compounds → | |||
Synergistic Research Application Notice
In comprehensive endocrine research lines, investigators frequently cross-examine AOD 9604 in parallel with incretin analogues to observe multi-pathway metabolic adaptations. The 5mg format provides the exact flexibility required to establish baseline low-dose parameters before scaling into broad combination curves. While incretin series catalog options look into hunger signaling tracks or insulin secretion markers, standalone AOD 9604 offers a pristine reference loop for isolated lipid breakdown observation.
How to Store AOD 9604 Lyophilized Powder & Liquid Solutions
How to Store AOD 9604 Lyophilized Powder & Liquid Solutions
To keep your high-purity AOD 9604 peptide stable and prevent its delicate C-terminal chain sequence from breaking down early, you must follow strict temperature and environment parameters. Proper handling ensures that your laboratory assay baselines remain consistent and free from degradation artifacts over time.
- FREEZER (-20°C) Lyophilized Peptide Powder: Store the dry crystalline powder inside a laboratory freezer at -20°C to -80°C for long-term storage. This fully seals the peptide configuration against degradation loops for up to 24 months.
- ROOM TEMP (25°C) Shipping & Transit Window: In its dry, vacuum-desiccated solid cake state, AOD 9604 is highly resilient. It can easily endure ambient transport fluctuations up to 25°C for a maximum of 3 weeks. Always return the vials to deep-freeze storage upon delivery.
- REFRIGERATOR (2°C – 8°C) Reconstituted Liquid Phase: Once mixed into a liquid form, the solution must be stored strictly under refrigeration between 2°C and 8°C. Reconstituted fluid phases face natural structural decay; completely exhaust the active liquid within 10 to 14 days maximum. Never freeze a peptide after it has been liquified.
Step-by-Step AOD 9604 Reconstitution Guide
Because short-chain peptide matrices are highly sensitive to sudden physical pressure shifts, follow this precise protocol to dissolve your 5mg AOD 9604 powder cake into a stable fluid layer:
- Temperature Adjusting: Allow the 5mg AOD 9604 vial to naturally reach ambient room temperature equilibrium before removing the plastic security cap. This step blocks condensation moisture from contaminating the dry cake.
- Sanitizing the Septum: Thoroughly clean the upper rubber entry core septum using a fresh, high-grade isopropyl alcohol sterile wipe.
- Gentle Liquid Cascade: Draw your laboratory diluent (such as sterile bacteriostatic water) and slowly inject 1ml down the internal glass envelope wall. Let the fluid cascade gently down the glass rather than spraying it directly at the powder to avoid structural kinetic shock paths.
- Zero Aggressive Agitation: Do not shake, vibrate, or vortex the vial. Mechanical friction shears peptide chains easily. Instead, gently roll and rotate the vial horizontally in circular, concentric movements until the white solid cake fully transitions into a pristine, crystal-clear transparent liquid layer.
There are no reviews yet.